How To Predict Breast Cancer Relapse?

Scientists from Cambridge and Stanford universities have performed the research that shows breast cancer can be subcategorized into 11 separate types.

The hope is that by identifying the subtypes of breast cancer it could facilitate risk estimation of its reoccurrence, as various types have a difference chance of relapse. Some categories have a tendency of reoccurrence within 10 years after the initial diagnosis, while the others are not likely to come back. This becomes highly important as the findings could potentially ensure closer monitoring of those who are at the higher risk.

GCT has completed numerous cancer studies, including breast cancer clinical trials. We look forward to further promising updates on the research.


Source: Nature Journal 

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.